Xiaflex was approved in 2010 for the treatment of Dupuytren’s contracture. Dupuytren’s contracture is a condition where nodules form under the skin in the palm of the hand. These nodules thicken and ...

Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is effective in reducing nodule hardness and nodule size. Researchers at the Kennedy Institute, University of Oxford, led by ...

Dupuytren's disease is a common condition that many people have probably never heard of. The disease causes knots of tissue to form under the skin of the hand, slowly pulling one or more fingers into ...

Results of a phase 2b trial led by researchers at Oxford University’s Kennedy Institute have shown that the anti-TNF drug adalimumab is effective for treating early-stage Dupuytren's disease.

DUBLIN--(BUSINESS WIRE)--The "Dupuytren's Disease Market Size, Share & Trends Analysis Report By Type (Diagnosis, Treatment), By Disease Type (Type I, Type II), By End-use (Hospitals, Clinics), By ...

Dupuytren’s disease is often referred to as “the most common crippling hand condition that people have never heard of,” but Kurt Harrington is on a mission to change that. A seasoned biotech and ...

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early-stage Dupuytren's ...

Modern humans likely encountered Neanderthals in Europe around 45,000 years ago—and got to know each other rather closely. About 21,500 generations now sit between us and our extinct hominin cousins, ...

video: Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size providing hope to patients. view more Researchers at the ...